Treating a COPD exacerbation starts with fast-acting inhaled bronchodilators and, in most cases, a short course of oral corticosteroids. The specific combination of treatments depends on how severe the flare-up is, ranging from at-home inhaler use for mild episodes to hospital-based breathing support for serious ones. Getting treatment early makes a real difference: hospitalized exacerbations carry a 90-day readmission rate of about 35%, and each severe episode increases the risk of the next one.
Mild vs. Severe: Knowing What You’re Dealing With
Not every exacerbation needs a trip to the emergency department, but some absolutely do. A mild flare-up means you’re more breathless than usual and coughing more, but you can still speak in full sentences, walk short distances, and your breathing rate stays relatively normal. You can often manage these at home with adjustments to your medications.
Certain signs point to something more dangerous. Doctors look for a breathing rate that’s climbing fast, use of neck and chest muscles to breathe (you can feel yourself straining with each breath), inability to finish a sentence without gasping, confusion or drowsiness, and a bluish tint to your lips or fingertips. Any of these warrants emergency care. If your oxygen levels drop very low or your blood becomes too acidic from carbon dioxide buildup (a pH below 7.25), intensive care may be needed.
Fast-Acting Inhalers: The First Step
The cornerstone of immediate treatment is a short-acting bronchodilator, a rescue inhaler that relaxes the muscles around your airways within minutes. The most common is salbutamol (sold as Ventolin and other brands), typically one to two puffs as needed. In an emergency setting, this is often given through a nebulizer, which turns the medication into a fine mist you breathe continuously.
A second type of fast-acting inhaler, ipratropium bromide, works through a different mechanism. It blocks the nerve signals that cause airways to tighten. The usual dose is two puffs three to four times daily, with a maximum of 12 puffs in 24 hours and at least four hours between doses. During a significant exacerbation, doctors frequently combine both types, either as separate inhalers or as a combination product, because they open the airways through complementary pathways and together produce a stronger effect than either alone.
Corticosteroids to Reduce Inflammation
Oral corticosteroids, most commonly prednisone, are standard for moderate to severe flare-ups. They tamp down the inflammation that’s swelling your airway walls and producing excess mucus. The typical prescription is 30 to 60 mg of prednisone daily for five to seven days, sometimes followed by a gradual taper over one to two weeks depending on how quickly you improve. In the hospital, an intravenous form may be used initially before switching to pills.
Not everyone benefits equally from steroids. A simple blood test measuring eosinophils, a type of white blood cell involved in inflammation, can help predict your response. People with an eosinophil level at or above 2% of their total white cell count (roughly 300 cells per microliter) tend to see the greatest improvement in lung function and symptom relief from corticosteroids. Those with lower eosinophil counts may get less benefit, and some clinicians are beginning to use this marker to avoid unnecessary steroid courses and their side effects.
When Antibiotics Are Needed
Antibiotics are not automatic with every exacerbation. They help when the flare-up is driven by a bacterial infection, and clinicians use a straightforward set of criteria to decide. The key signs are increased coughing, increased sputum volume, and sputum that has turned yellow, green, or brown (purulent). When at least two of these three symptoms are present, antibiotics typically provide meaningful benefit. If you’re just more short of breath but your sputum looks the same as usual, a viral trigger or environmental irritant is more likely and antibiotics won’t help.
For uncomplicated cases in people under 65 with relatively preserved lung function and fewer than two exacerbations per year, first-line options include common antibiotics like amoxicillin-clavulanate, azithromycin, doxycycline, or cefuroxime. A typical course lasts five to seven days. People with more compromised lung function, frequent exacerbations, or heart disease may need broader-spectrum antibiotics, as they’re more likely to harbor resistant bacteria.
Oxygen: Why Too Much Can Be Harmful
Supplemental oxygen is essential when your blood oxygen drops too low, but in COPD, there’s a critical difference from how oxygen is managed in other conditions. The target saturation range is 88% to 92%, noticeably lower than the 94% to 98% target used for most other patients. This isn’t an oversight.
In COPD, pushing oxygen levels higher can trigger a dangerous buildup of carbon dioxide in the blood. This happens primarily because extra oxygen disrupts the balance of blood flow and ventilation in your lungs, and can also reduce your breathing drive. The result, called oxygen-induced hypercapnia, can lead to worsening drowsiness, respiratory acidosis, and in severe cases death. Research on hospitalized COPD patients has confirmed that those maintained at 88% to 92% saturation had the highest survival rates compared to patients with higher oxygen levels. This applies regardless of whether you’ve had carbon dioxide problems before.
Breathing Support for Severe Episodes
When standard medications and controlled oxygen aren’t enough, the next step is non-invasive ventilation (NIV), a machine that delivers pressurized air through a snug face mask to help your lungs move air in and out. It’s considered when blood acidity drops to a pH of 7.35 or below, carbon dioxide levels rise above 45 mmHg, and your breathing rate stays above 20 to 24 breaths per minute despite treatment.
NIV reduces the work your breathing muscles have to do, buys time for medications to take effect, and in many cases prevents the need for intubation (a breathing tube placed in your throat connected to a mechanical ventilator). If NIV fails or if you arrive in severe distress with altered consciousness and dangerously low oxygen, mechanical ventilation in an ICU becomes necessary.
What Happens After the Acute Phase
The days and weeks following an exacerbation are a high-risk window. About one in three people discharged from the hospital for a COPD exacerbation are readmitted within 90 days, and readmission itself is strongly linked to a higher risk of death. Previous hospitalizations are the strongest predictor of being readmitted, meaning each severe episode compounds the danger of the next.
Discharge planning ideally begins within 24 to 48 hours of admission. The most effective post-discharge programs bundle several interventions together: checking and correcting inhaler technique (which is poor far more often than people realize), optimizing daily medications, providing a written action plan for future flare-ups, screening for depression and acid reflux (both of which worsen COPD outcomes), and connecting you with pulmonary rehabilitation. A follow-up phone call at 48 to 72 hours after discharge, with another check-in at 7 to 10 days, helps catch early signs of relapse.
Pulmonary rehabilitation deserves special emphasis. It combines supervised exercise training with education on breathing techniques and self-management. Starting it soon after an exacerbation reduces the risk of future hospitalizations and improves both exercise tolerance and quality of life. If you’ve been hospitalized and haven’t been referred, it’s worth asking about. Smoking cessation, if applicable, remains the single most impactful intervention for slowing COPD progression and reducing exacerbation frequency over time.